SCHEMBL22901607

SCHEMBL22901607

CCOc1cccc(COc2cc(C)cc3ccc(-c4nccc(C)n4)nc23)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
MAPT P10636 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
HTT P42858 1/20 0.36
F2RL3 Q96RI0 2/20 0.35
KDM4E B2RXH2 1/20 0.35
LMNA P02545 1/20 0.35
GCK P35557 1/20 0.35
MAOB P27338 3/20 0.34
MRGPRX4 Q96LA9 2/20 0.34
TP53 P04637 1/20 0.34
PKM P14618 1/20 0.34
NFKB1 P19838 1/20 0.34
NFKB2 Q00653 1/20 0.34
RELA Q04206 1/20 0.34
DHFR P00374 1/20 0.34
FFAR1 O14842 2/20 0.34
SYK P43405 1/20 0.34
PPARD Q03181 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22901548 0.92 MAPT (0.45) MEN1KMT2AMAPTSMN1; SMN2HTT
SCHEMBL22901549 0.83 MAPT (0.48) MAPTSMN1; SMN2HTTGCKMAOB
SCHEMBL22901571 0.83 MAPT (0.48) MEN1KMT2AMAPTSMN1; SMN2HTT
SCHEMBL22901561 0.83 MAOB (0.46) MEN1KMT2AMAPTSMN1; SMN2HTT
SCHEMBL22901552 0.82 MAPT (0.43) MEN1KMT2AMAPTSMN1; SMN2HTT
SCHEMBL22901547 0.81 MEN1 (0.51) MEN1KMT2AMAPTSMN1; SMN2HTT
SCHEMBL22901542 0.78 MAPT (0.47) MAPTSMN1; SMN2HTTGCKMAOB
SCHEMBL22901565 0.78 MAPT (0.47) MAPTSMN1; SMN2HTTGCKMAOB
SCHEMBL22901579 0.76 MAPT (0.46) MAPTSMN1; SMN2HTTGCKMAOB
SCHEMBL22901578 0.75 MAOB (0.48) MEN1KMT2AMAPTSMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021008588-A1 CLASS OF PYRIMIDINE QUINOLINE DERIVATIVES AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 广州新民培林医药科技有限公司 2021-01-21 WO disclosed